bioRxivSystems BiologyPreprint
Not by systems alone: replicability assessment of disease expression signals
Sara BallouziD, Max Johannes Dörfel, Megan CrowiD, Jonathan Crain, Laurence Olivier FaivreiD, Catherine E. KeeganiD, Sophia Kitsiou‐Tzeli, Maria TzetisiD, Gholson J. LyoniD, Jesse A GillisiD
Abstract
In characterizing a disease, it is common to search for dysfunctional genes by assaying the transcriptome. The resulting differentially expressed genes are typically assessed for shared features, such as functional annotation or co-expression. While useful, the reliability of these systems methods is hard to evaluate. To better understand shared disease signals, we assess their replicability by first looking at gene-level recurrence and then pathway-level recurrence along with co-expression signals across six pedigrees of a rare homogeneous X-linked disorder, TAF1 syndrome. We find most differentially expressed genes are not recurrent between pedigrees, making functional enrichment largely distinct in each pedigree. However, we find two highly recurrent \"functional outliers\" (CACNA1I and IGFBP3), genes acting atypically with respect to co-expression and therefore absent from a systems-level assessment. We show this occurs in re-analysis of Huntingtons disease, Parkinsons disease and schizophrenia. Our results suggest a significant role for genes easily missed in systems approaches.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Reproducibility Focused Meta-Analysis Method for Single-Cell Transcriptomic Case-Control Studies Uncovers Robust Differentially Expressed Genes
Nathan J. Nakatsuka, Drew I. Adler, … Rahul Satija·bioRxiv·Oct 15, 2024
- Directional Gene-Level Concordance and Methodological Constraints in Blood Transcriptomic and DNA Methylation Studies of Parkinson's Disease
Chiragh Dewan, Inayat Chauhan, … Rupinderjeet Kaur·bioRxiv·May 20, 2026
- Can we assume the gene expression profile as a proxy for signaling network activity?
Mehran Piran, Reza Karbalaei, … Mohieddin Jafari·BiomoleculesPeer-reviewed·Jun 3, 2020
- Collaborative network analysis for the interpretation of transcriptomics data in rare diseases, an application to Huntington's disease
Ozan Özışık, Nazli Sila Kara, … Eleni Mina·bioRxiv·Jul 22, 2023
- Towards a global investigation of transcriptomic signatures through co-expression networks and pathway knowledge for the identification of disease mechanisms
Rebeca Queiroz Figueiredo, Tamara Raschka, … Daniel Domingo‐Fernándéz·Nucleic Acids ResearchPeer-reviewed·Jun 11, 2021
- Recalibrating differential gene expression by genetic dosage variance prioritizes functionally relevant genes
Philipp Rentzsch, Aaron Kollotzek, … Tuuli Lappalainen·Genome ResearchPeer-reviewed·Oct 1, 2025